Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

The global active pharmaceutical ingredients (API) market was valued at USD 170.40 Billion in 2024, driven by the rising proliferation of chronic conditions resulting in a rise in demand for drugs across the globe. The market is anticipated to grow at a CAGR of 7.80% during the forecast period of 2025-2034 to achieve a value of USD 361.12 Billion by 2034.

2024

Base Year

2018-2024

Historical Year

2025-2034

Forecast Year

  • The rising prevalence of chronic diseases and increasing demand for personalised medicines are driving innovation and expanding the market.
  • Technological advancements in active pharmaceutical ingredient production, such as green chemistry and continuous manufacturing, are improving efficiency and enhancing the market growth globally.
  • Growing regulatory support for generic drug manufacturing and increasing outsourcing of active pharmaceutical ingredients to cost-effective regions are significantly boosting market development.

Compound Annual Growth Rate

Value in USD Billion

7.8%

2025-2034


Active Pharmaceutical Ingredients (API) Market Outlook

*this image is indicative*

Active Pharmaceutical Ingredients (API) Market Overview

Active Pharmaceutical Ingredients (APIs) are the biologically active components in pharmaceutical drugs responsible for their therapeutic effects. They are meticulously manufactured through chemical synthesis, fermentation, or biotechnology and play a crucial role in treating specific medical conditions. APIs are combined with excipients (inactive substances) to create the final drug formulation. Stringent regulatory standards govern their production to ensure quality, safety, and efficacy. APIs are classified into synthetic and biological, with the latter gaining prominence due to advancements in biotechnology. They are integral to the pharmaceutical industry, addressing diverse therapeutic needs and driving innovations in modern medicine.

Active Pharmaceutical Ingredients (API) Market Growth Drivers

Diversification of Pharmaceutical Supply Chain Driving the Market 

Growing investments in enhancing manufacturing capabilities and improving supply chain resilience are significant drivers of the market. For instance, In May  2024, the United States Agency for International Development (USAID) launched a project aimed at diversifying Asia’s pharmaceutical supply chain by providing USD 5 million to improve the production, regulation, and export of APIs in Uzbekistan and Kazakhstan. The initiative will strengthen critical sectors such as manufacturing, governance, regulatory systems, and workforce development. By boosting local production and reducing reliance on imports, this project is set to enhance competitiveness in Central Asia, improve supply chain stability, and reduce disruptions, thereby supporting growth in the API market over the forecast period.

Domestic Pharmaceutical Supply Chain Enhancement to Drive Active Pharmaceutical Ingredients (API) Market Demand

The growing need for robust domestic pharmaceutical supply chains and quality assurance drives the expansion of the market. For instance, in March  2024, Noramco announced the creation of Noramco Group, which integrates its subsidiaries Halo Pharma and Purisys. This strategic move aims to address drug shortages and quality concerns in the United States by enhancing supply chain reliability and boosting domestic production. With the current challenges of unreliable foreign supply and insufficient local manufacturing capacity, this initiative is set to strengthen the US pharmaceutical sector. The integration of these companies is expected to improve supply chain performance, reduce costs, and ensure greater market stability, positioning the API market for significant growth in the forecast period.

Active Pharmaceutical Ingredients (API) Market Trends

Active Pharmaceutical Ingredients (API) Market Segmentation

Active Pharmaceutical Ingredients Market by Drug Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Active Pharmaceutical Ingredients (API) Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:

Market Breakup by Molecule

  • Small Molecule 
  • Large Molecule

Market Breakup by Type

  • Innovative APIs 
  • Generic APIs 

Market Breakup by Type of Drug

  • Prescription Drugs 
  • Over-the -Counter Drugs

Market Breakup by Therapeutic Application

  • Communicable Diseases 
  • Oncology 
  • Cardiovascular Diseases 
  • Respiratory Diseases 
  • Pain Management 
  • Diabetes 
  • Others

Market Breakup by End User

  • Pharmaceutical and Biotechnology Industry 
  • Contract Research and Manufacturing Organizations (CROs/CMOs) 
  • Others

Market Breakup by Region

North America 
Europe  
Asia Pacific 
Latin America 
Middle East and Africa

Active Pharmaceutical Ingredients (API) Market Share

Small Molecule APIs to Lead the Segmentation by Molecule

Small molecule APIs are likely to dominate the market due to their widespread use in treating chronic and infectious diseases. As per the analysis  by Expert Market Research, the global small molecule API market is anticipated to grow at a CAGR of 6.8% during the forecast period of 2025-2034. Their high oral bioavailability, cost-effectiveness, and compatibility with various drug formulations make them a preferred choice. Increasing demand for generic drugs and advancements in chemical synthesis techniques are key drivers for their growth. In the forecast period, the small molecule segment is poised to sustain its leadership, supported by rising investments in drug discovery and expanding therapeutic applications, ensuring its pivotal role in driving market growth.

Active Pharmaceutical Ingredients (API) Market Segmentation by Type to Witness Growth

Generic APIs are poised to hold the largest market share due to their affordability and high demand in emerging economies. The expiration of patents for major drugs and governmental initiatives promoting generic medicines significantly contribute to their growth. Manufacturers increasingly focus on scaling up production to meet the global demand for cost-effective treatments. This segment is expected to drive market growth as healthcare providers prioritise affordability and accessibility, ensuring continued expansion in both developed and developing regions during the forecast period.

Prescription Drugs Driving the Market Segment by Type of Drug

Prescription drugs will likely lead the market due to their crucial role in managing complex and chronic conditions. The increasing prevalence of lifestyle-related diseases and rising healthcare expenditure are significant drivers. Advancements in targeted drug delivery and personalised medicine further enhance the importance of prescription APIs. During the forecast period, this segment is poised to grow steadily as demand for high-quality treatments rises, supported by ongoing innovations and the growing adoption of advanced therapeutic solutions globally.

Oncology to Leading the Active Pharmaceutical Ingredients (API) Market by Therapeutic Application

Oncology is likely to reserve the largest share in the market due to the growing global incidence of cancer. Innovations in targeted therapies and biologic drugs, along with increasing research funding, are driving demand. As per the analysis  by Expert Market Research, the oncology drugs market is expected to grow at a CAGR of 13.2% during the forecast period of 2025-2034. Governments and pharmaceutical companies are heavily investing in cancer treatment solutions to address unmet needs. This segment is expected to experience substantial growth as advancements in precision medicine and immunotherapies continue to expand therapeutic possibilities, positioning oncology APIs as a critical driver of the market during the forecast period.

Pharmaceutical and Biotechnology Industry Dominating the Segment by End User

The pharmaceutical and biotechnology industry is poised to lead the market as the primary consumer of high-quality APIs. Growing R&D investments, particularly in biologics and specialty drugs, are significant market drivers. Increasing collaborations and partnerships between pharma companies and research organisations further accelerate API adoption. This segment is expected to grow robustly during the forecast period, driven by rising demand for innovative drug formulations, regulatory compliance needs, and expansion of manufacturing capabilities, solidifying its dominance in the market.

Active Pharmaceutical Ingredients (API) Market Analysis by Region

The Asia Pacific region is poised to dominate the market due to its well-established manufacturing infrastructure, cost-efficient production capabilities, and robust talent pool. Countries like India and China lead with strong raw material availability, favourable policies, and significant export activities. North America is likely to hold a substantial market share driven by advanced R&D capabilities, stringent regulatory standards, and increasing demand for high-value APIs. Europe is a key player, leveraging its pharmaceutical innovations and high-quality standards. Latin America is emerging with growing local production and regional partnerships, while the Middle East and Africa demonstrate gradual growth with rising healthcare investments and increased focus on generics. Collectively, each region contributes distinctively to the global API landscape.

Leading Players in the Active Pharmaceutical Ingredients (API) Market

The key features of the market report comprise patent analysis, clinical trials analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Novartis AG

Headquartered in Basel, Switzerland, Novartis AG was established in 1996 following the merger of Ciba-Geigy and Sandoz. A global leader in the pharmaceutical sector, Novartis specialises in innovative medicines, generics, and biosimilars. The company’s active pharmaceutical ingredient (API) portfolio includes small molecules, biologics, and advanced therapies addressing critical diseases such as cancer, cardiovascular conditions, and immunological disorders. Novartis leverages cutting-edge technologies and a strong research network to meet global API market demands while maintaining a focus on sustainability and healthcare accessibility.

Bayer AG

Founded in 1863 and headquartered in Leverkusen, Germany, Bayer AG is a global leader in pharmaceuti...

GLENMARK PHARMACEUTICALS LTD.

Established in 1977 and headquartered in Mumbai, India, Glenmark Pharmaceuticals Ltd. is a global ph...

GlaxoSmithKline plc

GlaxoSmithKline plc (GSK), headquartered in Brentford, England, was founded in 2000 following a merg...

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Other key players in the market include Merck KGaA, Aurobindo Pharma, AstraZeneca Plc, Elam Pharma Pvt. Ltd., Teva Pharmaceutical Industries Ltd., and Sanofi SA. 

Key Questions Answered in the Active Pharmaceutical Ingredients (API) Market

  • What was the global active pharmaceutical ingredients (API) market value in 2024?
  • What is the active pharmaceutical ingredients (API) market forecast outlook for 2025-2034?
  • What is market segmentation based on molecule?
  • What is market segmentation based on type?
  • How is the market segmented based on type of drug?
  • How is the market segmented based on therapeutic application?
  • What is market segmentation based on end users?
  • What are the major factors aiding the active pharmaceutical ingredients (API) market demand?  
  • How has the market performed so far and how is it anticipated to perform in the coming years? 
  • What are the market's major drivers, opportunities, and restraints?
  • What are the major active pharmaceutical ingredients (API) market trends?
  • Which molecule will lead the market segment?  
  • Which type will lead the market segment?  
  • Which type of drug will lead the market segment?  
  • Which therapeutic application will lead the market segment?  
  • Which end user will lead the market segment?  
  • Who are the key players involved in the active pharmaceutical ingredients (API) market? 
  • What is the patent landscape of the market? 
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2024
Historical Period 2018-2024
Forecast Period 2025-2034
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Molecule
  • Type
  • Type of Drug
  • Therapeutic Application
  • End User
  • Region
Breakup by Molecule
  • Small Molecule
  • Large Molecule
Breakup by Type
  • Innovative APIs
  • Generic APIs
Breakup by Type of Drug
  • Prescription Drugs
  • Over-the -Counter Drugs
Breakup by Therapeutic Application
  • Communicable Diseases
  • Oncology
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Pain Management
  • Diabetes
  • Others
Breakup by End User
  • Pharmaceutical and Biotechnology Industry
  • Contract Research and Manufacturing Organizations (CROs/CMOs)
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • PESTEL Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Company News and Developments
    • Certifications
Companies Covered
  • Novartis AG
  • Bayer AG
  • GLENMARK PHARMACEUTICALS LTD.
  • GlaxoSmithKline plc
  • Merck KGaA
  • Aurobindo Pharma
  • AstraZeneca Plc
  • Elam Pharma Pvt. Ltd.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.

Single User License

10 % Off

USD

5,499

4,949

Datasheet

10 % Off

USD

3,299

2,969

Five User License

15 % Off

USD

6,999

5,949

Corporate License

15 % Off

USD

8,199

6,969

Single User License

One User

USD 5,499

USD 4,949

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Datasheet

One User

USD 3,299

USD 2,969

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Five User License

Five User

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 8,199

USD 6,969

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124